Raises FY25 adjusted EBITDA view to $273M-$287M from $270M-$286M.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GDRX:
- Notable companies reporting before tomorrow’s open
- GoodRx price target lowered to $7 from $8 at Wells Fargo
- GoodRx Holdings: Strategic Positioning and Cost Advantages Support Buy Rating Amidst Competitive Landscape
- GoodRx price target lowered to $5.50 from $6.50 at Truist
- Cautious Outlook for GoodRx Holdings Amid Limited Partnership Impact and Industry Challenges
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue